# Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

> **NCT03649750** · PHASE1 · COMPLETED · sponsor: **Reckitt Benckiser LLC** · enrollment: 36 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Mucinex®

## Key facts

- **NCT ID:** NCT03649750
- **Lead sponsor:** Reckitt Benckiser LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-29
- **Primary completion:** 2013-08-07
- **Final completion:** 2013-08-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649750, "Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03649750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*